The GLP-1 Bridge Program: Price Fixing vs. Free Market Healthcare

Jay Goldberg, North American Affairs Manager at the Consumer Choice Center, discusses the implications of the GLP-1 Bridge Program on healthcare regulation, drug pricing, and consumer advocacy in the latest episode of the Health Policy Podcast. Key topics include the impact on healthcare access and the balance between government intervention and free market principles.

WASHINGTON — September 25, 2026 — In a recent episode of the Health Policy Podcast, Jay Goldberg from the Consumer Choice Center examined the GLP-1 Bridge Program, a government initiative aimed at providing lower-cost access to weight loss medications for Medicare and Medicaid recipients. The discussion focused on the program's implications for healthcare regulation, drug pricing, and consumer choice.

Goldberg highlighted the potential downsides of the GLP-1 Bridge Program, arguing that it promotes price fixing, which could undermine innovation in the pharmaceutical industry. "What the GLP-1 Bridge Program does is that it essentially embraces price fixing," he said. He emphasized that while the program offers a fixed price of $50 per month for eligible patients, the true cost to taxpayers is significantly higher, raising concerns about the sustainability of medical innovation.

The conversation also addressed the importance of competition in healthcare. Goldberg stated, "The way to actually reduce costs in the medical system is through competition." He stressed that fostering a competitive environment among pharmaceutical companies is essential for driving down prices and ensuring timely access to new treatments.

The Consumer Choice Center advocates for consumer choice across various sectors, including healthcare, energy, and trade. The organization promotes policies that empower individuals to make informed decisions and prioritize their preferences.

About the Health Policy Podcast

The Health Policy Podcast focuses on issues related to energy, infrastructure, policy, and economic growth. The show features expert guests and discussions that explore the intersection of health policy and broader economic themes.